Bile salt hydrolase activity in probiotics.

PubWeight™: 2.19‹?› | Rank: Top 2%

🔗 View Article (PMC 1393245)

Published in Appl Environ Microbiol on March 01, 2006

Authors

Máire Begley1, Colin Hill, Cormac G M Gahan

Author Affiliations

1: Department of Microbiology, University College Cork, College Road, Cork, Ireland.

Articles citing this

Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38

Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev (2007) 3.61

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53

Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10

Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A (2014) 1.50

Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci (2010) 1.41

Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl Environ Microbiol (2008) 1.29

The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 1.22

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res (2012) 1.17

Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum. Appl Environ Microbiol (2007) 1.17

Adaptation and response of Bifidobacterium animalis subsp. lactis to bile: a proteomic and physiological approach. Appl Environ Microbiol (2007) 1.13

Virulence or niche factors: what's in a name? J Bacteriol (2012) 1.05

Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med (2011) 1.02

Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG. Mol Cell Proteomics (2010) 1.02

Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol (2008) 1.00

Catabolism and biotechnological applications of cholesterol degrading bacteria. Microb Biotechnol (2012) 1.00

Effect of Antibiotic Growth Promoters on Intestinal Microbiota in Food Animals: A Novel Model for Studying the Relationship between Gut Microbiota and Human Obesity? Front Microbiol (2011) 1.00

The human gut mobile metagenome: a metazoan perspective. Gut Microbes (2011) 0.99

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. MBio (2016) 0.99

Immobilization technologies in probiotic food production. J Nutr Metab (2013) 0.93

Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut. PLoS One (2013) 0.93

Characterization of a novel Lactobacillus species closely related to Lactobacillus johnsonii using a combination of molecular and comparative genomics methods. BMC Genomics (2010) 0.92

The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes (2014) 0.92

Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial. J Res Med Sci (2014) 0.90

Probiotic properties of Lactobacillus strains isolated from Tibetan kefir grains. PLoS One (2013) 0.90

The effects of two Lactobacillus plantarum strains on rat lipid metabolism receiving a high fat diet. ScientificWorldJournal (2013) 0.90

Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J (2014) 0.89

Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes (2016) 0.89

Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J Gastroenterol (2013) 0.88

The ABC-type multidrug resistance transporter LmrCD is responsible for an extrusion-based mechanism of bile acid resistance in Lactococcus lactis. J Bacteriol (2008) 0.88

Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients (2016) 0.87

The Intestinal Microbiota in Metabolic Disease. Nutrients (2016) 0.87

Discovery of bile salt hydrolase inhibitors using an efficient high-throughput screening system. PLoS One (2014) 0.87

Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters. Appl Environ Microbiol (2012) 0.87

Probiotics and chronic kidney disease. Kidney Int (2015) 0.86

Bifidobacteria-host interactions--an update on colonisation factors. Biomed Res Int (2014) 0.85

Identification of proteins related to the stress response in Enterococcus faecalis V583 caused by bovine bile. Proteome Sci (2010) 0.85

A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb Cell Fact (2015) 0.85

Antibacterial and Antioxidant Activities of Acid and Bile Resistant Strains of Lactobacillus fermentum Isolated from Miang. Braz J Microbiol (2009) 0.84

Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet. Lipids Health Dis (2013) 0.83

Technological properties and probiotic potential of Lactobacillus fermentum strains isolated from West African fermented millet dough. BMC Microbiol (2015) 0.83

Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids Health Dis (2011) 0.83

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol (2016) 0.83

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes (2016) 0.82

Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol (2016) 0.82

Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota? Adv Nutr (2016) 0.82

Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) (2015) 0.82

Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut. Dig Dis (2015) 0.81

Apples and cardiovascular health--is the gut microbiota a core consideration? Nutrients (2015) 0.80

Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome. Bioeng Bugs (2012) 0.80

Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome. J Funct Foods (2015) 0.80

The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/- mice. PLoS One (2013) 0.80

Hypolipidemic effects and safety of Lactobacillus reuteri 263 in a hamster model of hyperlipidemia. Nutrients (2015) 0.80

Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk. Gut Microbes (2014) 0.80

Preliminary evaluation of probiotic properties of Lactobacillus strains isolated from Sardinian dairy products. Biomed Res Int (2014) 0.79

Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur J Nutr (2012) 0.79

Functional role of oppA encoding an oligopeptide-binding protein from Lactobacillus salivarius Ren in bile tolerance. J Ind Microbiol Biotechnol (2015) 0.78

Purification of Antilisterial Peptide (Subtilosin A) from Novel Bacillus tequilensis FR9 and Demonstrate Their Pathogen Invasion Protection Ability Using Human Carcinoma Cell Line. Front Microbiol (2016) 0.78

A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol Biosyst (2014) 0.78

Bioaccessible antioxidants in milk fermented by Bifidobacterium longum subsp. longum strains. Biomed Res Int (2015) 0.78

Bile salt inhibition of host cell damage by Clostridium difficile toxins. PLoS One (2013) 0.78

Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. Int J Mol Sci (2014) 0.78

Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Int J Mol Sci (2016) 0.77

Hypocholesterolemic effects of Kluyveromyces marxianus M3 isolated from Tibetan mushrooms on diet-induced hypercholesterolemia in rat. Braz J Microbiol (2015) 0.77

Probiotic potential and safety properties of Lactobacillus plantarum from Slovak Bryndza cheese. Biomed Res Int (2013) 0.77

Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome. Microb Biotechnol (2016) 0.77

Pathophysiological role of host microbiota in the development of obesity. Nutr J (2016) 0.76

A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium. PLoS One (2014) 0.76

Integrated transcriptomic and proteomic analysis of the bile stress response in a centenarian-originated probiotic Bifidobacterium longum BBMN68. Mol Cell Proteomics (2014) 0.76

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5. Microorganisms (2015) 0.75

Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials. Medicine (Baltimore) (2016) 0.75

The Dynamic Interactions between Salmonella and the Microbiota, within the Challenging Niche of the Gastrointestinal Tract. Int Sch Res Notices (2014) 0.75

Identification of Lactic Acid Bacteria in Fruit Pulp Processing Byproducts and Potential Probiotic Properties of Selected Lactobacillus Strains. Front Microbiol (2016) 0.75

Hypocholesterolemic and Prebiotic Effects of a Whole-Grain Oat-Based Granola Breakfast Cereal in a Cardio-Metabolic "At Risk" Population. Front Microbiol (2016) 0.75

In vitro probiotic evaluation of phytase producing Lactobacillus species isolated from Uttapam batter and their application in soy milk fermentation. J Food Sci Technol (2014) 0.75

Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models. BMC Cancer (2016) 0.75

Obesity and microbiota: an example of an intricate relationship. Genes Nutr (2017) 0.75

Gut Function-Enhancing Properties and Metabolic Effects of Dietary Indigestible Sugars in Rodents and Rabbits. Nutrients (2015) 0.75

Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract. Anaerobe (2016) 0.75

Comparative genomic analysis of Lactobacillus plantarum ZJ316 reveals its genetic adaptation and potential probiotic profiles. J Zhejiang Univ Sci B (2016) 0.75

Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway. Mol Pharmacol (2016) 0.75

Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth. Front Microbiol (2016) 0.75

Effect of Bile Salt Hydrolase Inhibitors on a Bile Salt Hydrolase from Lactobacillus acidophilus. Pathogens (2014) 0.75

Draft Genome Sequence of Enterococcus mundtii QAUEM2808, Isolated from Dahi, a Fermented Milk Product. Genome Announc (2016) 0.75

Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism. Br J Nutr (2016) 0.75

Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey. Dermatol Ther (Heidelb) (2017) 0.75

Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile. J Microbiol (2017) 0.75

Characterization of Bile Salt Hydrolase from Lactobacillus gasseri FR4 and Demonstration of Its Substrate Specificity and Inhibitory Mechanism Using Molecular Docking Analysis. Front Microbiol (2017) 0.75

Gastroparesis and lipid metabolism-associated dysbiosis in Wistar Kyoto rats. Am J Physiol Gastrointest Liver Physiol (2017) 0.75

Table Olive Fermentation Using Starter Cultures with Multifunctional Potential. Microorganisms (2017) 0.75

Comparative genomics of Lactobacillus kefiranofaciens ZW3 and related members of Lactobacillus. spp reveal adaptations to dairy and gut environments. Sci Rep (2017) 0.75

Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients (2017) 0.75

Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats. J Nutr Biochem (2017) 0.75

Performance, biochemical and haematological responses, and relative organ weights of laying hens fed diets supplemented with prebiotic, probiotic and synbiotic. BMC Vet Res (2017) 0.75

Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts. Front Med (Lausanne) (2017) 0.75

Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA. PLoS One (2017) 0.75

Articles cited by this

The interaction between bacteria and bile. FEMS Microbiol Rev (2005) 3.86

How do bacteria resist human antimicrobial peptides? Trends Microbiol (2002) 3.76

Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature (2002) 3.03

Lipid intermolecular hydrogen bonding: influence on structural organization and membrane function. Biochim Biophys Acta (1987) 2.91

Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80

In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr (2001) 2.73

Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol (2002) 2.70

Using probiotics and prebiotics to improve gut health. Drug Discov Today (2003) 2.66

Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res (2005) 2.64

Probiotics. Int J Food Microbiol (1998) 2.52

Barriers to intron promiscuity in bacteria. J Bacteriol (2000) 2.29

Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity. Appl Environ Microbiol (1987) 2.14

Probiotic bacteria: safety, functional and technological properties. J Biotechnol (2000) 2.05

Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes. Infect Immun (2005) 1.90

Lactobacilli and bile salt hydrolase in the murine intestinal tract. Appl Environ Microbiol (1989) 1.84

Role of bile acids in colorectal carcinogenesis. Eur J Cancer (1995) 1.66

Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des (2003) 1.66

Deconjugation of bile acids by intestinal lactobacilli. Appl Environ Microbiol (1977) 1.66

Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors. Gut (1986) 1.64

Cloning and expression of a conjugated bile acid hydrolase gene from Lactobacillus plantarum by using a direct plate assay. Appl Environ Microbiol (1992) 1.64

Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii 100-100. J Bacteriol (1998) 1.56

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol (2002) 1.56

Development of a differential medium for bile salt hydrolase-active Lactobacillus spp. Appl Environ Microbiol (1989) 1.55

Market potential for probiotics. Am J Clin Nutr (2001) 1.50

Bile stress response in Listeria monocytogenes LO28: adaptation, cross-protection, and identification of genetic loci involved in bile resistance. Appl Environ Microbiol (2002) 1.46

Selection and design of probiotics. Int J Food Microbiol (1999) 1.43

7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology (1996) 1.39

Significance of bile salt hydrolytic activities of lactobacilli. J Appl Bacteriol (1995) 1.37

Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 1.37

Purification and characterization of bile salt hydrolase from Clostridium perfringens. J Lipid Res (1988) 1.35

DNA micro-array-based identification of bile-responsive genes in Lactobacillus plantarum. J Appl Microbiol (2006) 1.35

Penicillin V acylase crystal structure reveals new Ntn-hydrolase family members. Nat Struct Biol (1999) 1.35

Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809. J Bacteriol (2005) 1.35

Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int J Food Microbiol (1998) 1.33

Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization. Appl Environ Microbiol (2000) 1.32

Characterization and purification of bile salt hydrolase from Lactobacillus sp. strain 100-100. J Bacteriol (1990) 1.30

Isolation of a bile salt sulfatase-producing Clostridium strain from rat intestinal microflora. Appl Environ Microbiol (1982) 1.26

Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta (1976) 1.25

Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci (1999) 1.24

Probiotics and human health: a clinical perspective. Postgrad Med J (2004) 1.23

The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol (1993) 1.21

Colonic bacterial activity, biliary cholesterol saturation, and pathogenesis of gallstones. Lancet (1978) 1.20

Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci (1999) 1.19

Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species. Microbiology (2001) 1.19

Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology (2000) 1.17

Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli. Appl Environ Microbiol (2001) 1.17

Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr (1998) 1.15

An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol (2003) 1.15

The role of penicillin amidases in nature and in industry. Trends Biochem Sci (1991) 1.13

Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes. Appl Environ Microbiol (1997) 1.13

Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci (2000) 1.13

Bile salt hydrolase activity of three strains of Lactobacillus acidophilus. J Dairy Sci (1999) 1.12

Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci (1998) 1.12

Sequencing and heterologous expression of the gene encoding penicillin V amidase from Bacillus sphaericus. Gene (1986) 1.12

Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product. Biochemistry (2005) 1.12

Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536. Appl Environ Microbiol (1995) 1.11

Effect of dietary carbohydrates on bacterial cholyltaurine hydrolase in poultry intestinal homogenates. Appl Environ Microbiol (1988) 1.11

Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens. Appl Environ Microbiol (1995) 1.10

Bile salts and cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri. J Appl Microbiol (2003) 1.08

Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum. J Dairy Sci (1998) 1.06

Biotransformations on steroid nucleus of bile acids. Steroids (1998) 1.05

Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J Biol Chem (1990) 1.05

Expression and characterization of a C24 bile acid 7 alpha-dehydratase from Eubacterium sp. strain VPI 12708 in Escherichia coli. J Lipid Res (1996) 1.04

Bile salt deconjugation by lactobacillus plantarum 80 and its implication for bacterial toxicity J Appl Microbiol (1999) 1.03

Probiotics in inflammatory bowel disease--therapeutic rationale and role. Adv Drug Deliv Rev (2004) 1.03

Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from Bacteroides vulgatus. J Biochem (1989) 1.02

Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts. Curr Microbiol (1995) 1.01

Cloning and characterization of the bile salt hydrolase genes (bsh) from Bifidobacterium bifidum strains. Appl Environ Microbiol (2004) 1.00

Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria. Microbiology (2003) 0.98

Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2005) 0.97

Multiple forms of bile salt hydrolase from Lactobacillus sp. strain 100-100. J Bacteriol (1992) 0.95

Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance. J Appl Microbiol (2000) 0.94

Bile salt hydrolase activity of Enterococci isolated from food: screening and quantitative determination. J Food Prot (2001) 0.94

Quantitative determination of bile salt hydrolase activity in bacteria isolated from the small intestine of chickens. Appl Environ Microbiol (2002) 0.94

Cholic acid is accumulated spontaneously, driven by membrane deltapH, in many lactobacilli. J Bacteriol (2000) 0.94

Bile salt toxicity to some bifidobacteria strains: role of conjugated bile salt hydrolase and pH. Can J Microbiol (2000) 0.92

Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol (1996) 0.91

Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut (1999) 0.91

Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol. J Biomed Biotechnol (2004) 0.90

Effect of heat-shock and bile salts on protein synthesis of Bifidobacterium longum revealed by [35S]methionine labelling and two-dimensional gel electrophoresis. FEMS Microbiol Lett (2005) 0.88

Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutr Cancer (1991) 0.87

Comparison of Lactobacillus strains with respect to bile salt hydrolase activity, colonization of the gastrointestinal tract, and growth rate of the murine host. Appl Environ Microbiol (1995) 0.86

Cloning and characterization of a bile salt hydrolase (bsh) from Bifidobacterium adolescentis. Biotechnol Lett (2005) 0.86

Expression, purification, crystallization and preliminary X-ray diffraction analysis of conjugated bile salt hydrolase from Bifidobacterium longum. Acta Crystallogr D Biol Crystallogr (2004) 0.84

Cloning of the bile salt hydrolase (bsh) gene from Enterococcus faecium FAIR-E 345 and chromosomal location of bsh genes in food enterococci. J Food Prot (2004) 0.84

Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains. J Dairy Sci (2004) 0.84

Measurement of bile salt hydrolase activity from Lactobacillus acidophilus based on disappearance of conjugated bile salts. J Dairy Sci (1999) 0.83

Bile salt-induced cytotoxicity and ursodeoxycholate cytoprotection: in-vitro study in perifused rat hepatocytes. Eur J Gastroenterol Hepatol (1997) 0.82

Improving lipid management--to titrate, combine or switch. Int J Clin Pract (2004) 0.81

Absence of cholic acid 7 alpha-dehydroxylase activity in the strains of Lactobacillus and Bifidobacterium. J Dairy Sci (1994) 0.81

Colonic transit influences deoxycholic acid kinetics. Gastroenterology (2001) 0.80

Characterization of cholylglycine hydrolase from a bile-adapted strain of Xanthomonas maltophilia and its application for quantitative hydrolysis of conjugated bile salts. Appl Environ Microbiol (2002) 0.79

Influence of pH on the phase distribution of nascent deoxycholic acid in fresh human cecal aspirates. Am J Physiol Gastrointest Liver Physiol (2001) 0.79

Fecal bile acid excretion profile in gallstone patients. Medicina (B Aires) (1999) 0.78

Articles by these authors

Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94

Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02

The interaction between bacteria and bile. FEMS Microbiol Rev (2005) 3.86

Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol Rev (2003) 3.54

Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence. FEMS Microbiol Rev (2002) 3.40

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A (2007) 3.32

Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol (2012) 2.76

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53

The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol (2006) 2.53

Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci (2005) 2.21

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A (2010) 2.11

The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. FEBS Lett (2004) 1.93

Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes. Infect Immun (2005) 1.90

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A (2010) 1.89

Tools for functional postgenomic analysis of listeria monocytogenes. Appl Environ Microbiol (2008) 1.78

A PrfA-regulated bile exclusion system (BilE) is a novel virulence factor in Listeria monocytogenes. Mol Microbiol (2005) 1.74

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68

The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol (2008) 1.62

Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry (2004) 1.61

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio (2012) 1.59

Bacteriocin production: a probiotic trait? Appl Environ Microbiol (2011) 1.57

Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol (2007) 1.54

Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog (2008) 1.53

Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes. Appl Environ Microbiol (2006) 1.50

Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46

Bile stress response in Listeria monocytogenes LO28: adaptation, cross-protection, and identification of genetic loci involved in bile resistance. Appl Environ Microbiol (2002) 1.46

Multiple deletions of the osmolyte transporters BetL, Gbu, and OpuC of Listeria monocytogenes affect virulence and growth at high osmolarity. Appl Environ Microbiol (2002) 1.46

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol (2006) 1.45

Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol (2011) 1.42

The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother (2002) 1.41

A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol (2007) 1.38

Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol (2011) 1.34

Disruption of putative regulatory loci in Listeria monocytogenes demonstrates a significant role for Fur and PerR in virulence. Infect Immun (2004) 1.34

The CtsR regulator of Listeria monocytogenes contains a variant glycine repeat region that affects piezotolerance, stress resistance, motility and virulence. Mol Microbiol (2003) 1.33

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol (2007) 1.33

Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother (2005) 1.30

Discovery of medically significant lantibiotics. Curr Drug Discov Technol (2009) 1.29

The interaction between Listeria monocytogenes and the host gastrointestinal tract. Microbiology (2009) 1.29

AgrD-dependent quorum sensing affects biofilm formation, invasion, virulence and global gene expression profiles in Listeria monocytogenes. Mol Microbiol (2009) 1.29

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol (2007) 1.27

A postgenomic appraisal of osmotolerance in Listeria monocytogenes. Appl Environ Microbiol (2003) 1.26

Molecular characterization of the arginine deiminase system in Listeria monocytogenes: regulation and role in acid tolerance. Environ Microbiol (2009) 1.26

Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem (2007) 1.26

Molecular and physiological analysis of the role of osmolyte transporters BetL, Gbu, and OpuC in growth of Listeria monocytogenes at low temperatures. Appl Environ Microbiol (2004) 1.24

Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microbiol (2005) 1.24

Presence of GadD1 glutamate decarboxylase in selected Listeria monocytogenes strains is associated with an ability to grow at low pH. Appl Environ Microbiol (2005) 1.22

Lantibiotic immunity. Curr Protein Pept Sci (2008) 1.22

Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe. Antimicrob Agents Chemother (2006) 1.21

Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett (2007) 1.21

Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci U S A (2005) 1.20

Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiology (2007) 1.20

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother (2009) 1.20

Relative ability of orally administered Lactobacillus murinus to predominate and persist in the porcine gastrointestinal tract. Appl Environ Microbiol (2004) 1.18

The dawning of a 'Golden era' in lantibiotic bioengineering. Mol Microbiol (2010) 1.18

Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl Environ Microbiol (2006) 1.17

The Dps-like protein Fri of Listeria monocytogenes promotes stress tolerance and intracellular multiplication in macrophage-like cells. Microbiology (2005) 1.17

Construction of p16Slux, a novel vector for improved bioluminescent labeling of gram-negative bacteria. Appl Environ Microbiol (2007) 1.17

Development of multiple strain competitive index assays for Listeria monocytogenes using pIMC; a new site-specific integrative vector. BMC Microbiol (2008) 1.16

Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16

The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol (2009) 1.16

Molecular pathogenesis of Listeria monocytogenes in the alternative model host Galleria mellonella. Microbiology (2010) 1.16

Isoprenoid biosynthesis in bacterial pathogens. Microbiology (2012) 1.16

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol (2010) 1.14

Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13

Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev (2011) 1.12

Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype. FEMS Microbiol Ecol (2008) 1.12

Customized care 2020: how medical sequencing and network biology will enable personalized medicine. F1000 Biol Rep (2009) 1.12

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol (2011) 1.11

Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation. Infect Immun (2007) 1.11

CesRK, a two-component signal transduction system in Listeria monocytogenes, responds to the presence of cell wall-acting antibiotics and affects beta-lactam resistance. Antimicrob Agents Chemother (2003) 1.10

The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol (2014) 1.10

The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob Agents Chemother (2010) 1.09